GB2331987B - Polycyclic sulphamate inhibitors of oestrone sulphatase - Google Patents

Polycyclic sulphamate inhibitors of oestrone sulphatase

Info

Publication number
GB2331987B
GB2331987B GB9725749A GB9725749A GB2331987B GB 2331987 B GB2331987 B GB 2331987B GB 9725749 A GB9725749 A GB 9725749A GB 9725749 A GB9725749 A GB 9725749A GB 2331987 B GB2331987 B GB 2331987B
Authority
GB
United Kingdom
Prior art keywords
sulphamate
polycyclic
inhibitors
oestrone sulphatase
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9725749A
Other languages
English (en)
Other versions
GB2331987A (en
GB2331987A9 (en
GB9725749D0 (en
Inventor
Michael John Reed
Barry Victor Lloyd Potter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Bath
Sterix Ltd
Imperial College of London
Original Assignee
University of Bath
Sterix Ltd
Imperial College of London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of GB2331987A9 publication Critical patent/GB2331987A9/en
Application filed by University of Bath, Sterix Ltd, Imperial College of London filed Critical University of Bath
Priority to GB9725749A priority Critical patent/GB2331987B/en
Publication of GB9725749D0 publication Critical patent/GB9725749D0/en
Priority to AT98957034T priority patent/ATE451107T1/de
Priority to EP98957034A priority patent/EP1051178B1/en
Priority to ES98957034T priority patent/ES2337427T3/es
Priority to DE69841374T priority patent/DE69841374D1/de
Priority to AU13458/99A priority patent/AU1345899A/en
Priority to JP2000522921A priority patent/JP2001524525A/ja
Priority to PCT/GB1998/003620 priority patent/WO1999027936A1/en
Publication of GB2331987A publication Critical patent/GB2331987A/en
Priority to US09/572,237 priority patent/US6670353B2/en
Application granted granted Critical
Publication of GB2331987B publication Critical patent/GB2331987B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
GB9725749A 1997-12-04 1997-12-04 Polycyclic sulphamate inhibitors of oestrone sulphatase Expired - Fee Related GB2331987B (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB9725749A GB2331987B (en) 1997-12-04 1997-12-04 Polycyclic sulphamate inhibitors of oestrone sulphatase
PCT/GB1998/003620 WO1999027936A1 (en) 1997-12-04 1998-12-03 Steroid 3-o-sulphamate derivatives as inhibitors of oestrone sulphatase
AT98957034T ATE451107T1 (de) 1997-12-04 1998-12-03 3-o-sulfamatsteroidderivate als hemmer von estronsulfatase
EP98957034A EP1051178B1 (en) 1997-12-04 1998-12-03 Steroid 3-o-sulphamate derivatives as inhibitors of oestrone sulphatase
ES98957034T ES2337427T3 (es) 1997-12-04 1998-12-03 Derivados esteroideos 3-o-sulfamato como inhibidores de estrona sulfatasa.
DE69841374T DE69841374D1 (de) 1997-12-04 1998-12-03 3-o-sulfamatsteroidderivate als hemmer von estronsulfatase
AU13458/99A AU1345899A (en) 1997-12-04 1998-12-03 Steroid 3-o-sulphamate derivatives as inhibitors of oestrone sulphatase
JP2000522921A JP2001524525A (ja) 1997-12-04 1998-12-03 エストロンスルファターゼのインヒビターとしてのステロイド３−ｏ−スルファメート誘導体
US09/572,237 US6670353B2 (en) 1997-12-04 2000-05-17 Oxime-group containing oestrone sulphatase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9725749A GB2331987B (en) 1997-12-04 1997-12-04 Polycyclic sulphamate inhibitors of oestrone sulphatase

Publications (4)

Publication Number Publication Date
GB2331987A9 GB2331987A9 (en) 1900-01-01
GB9725749D0 GB9725749D0 (en) 1998-02-04
GB2331987A GB2331987A (en) 1999-06-09
GB2331987B true GB2331987B (en) 2002-11-27

Family

ID=10823155

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9725749A Expired - Fee Related GB2331987B (en) 1997-12-04 1997-12-04 Polycyclic sulphamate inhibitors of oestrone sulphatase

Country Status (9)

Country Link
US (1) US6670353B2 (enExample)
EP (1) EP1051178B1 (enExample)
JP (1) JP2001524525A (enExample)
AT (1) ATE451107T1 (enExample)
AU (1) AU1345899A (enExample)
DE (1) DE69841374D1 (enExample)
ES (1) ES2337427T3 (enExample)
GB (1) GB2331987B (enExample)
WO (1) WO1999027936A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040127473A1 (en) * 1996-12-05 2004-07-01 Reed Michael John Compound
GB2331987B (en) 1997-12-04 2002-11-27 Imperial College Polycyclic sulphamate inhibitors of oestrone sulphatase
AU783910B2 (en) 1999-04-30 2005-12-22 Sterix Limited Use of estrone derivatives as antitumour agents
US7078395B1 (en) 1999-06-16 2006-07-18 Sterix Limited Methods for treating or preventing cancer by preventing, inhibiting or arresting cell cycling
GB9913536D0 (en) * 1999-06-10 1999-08-11 Sterix Ltd Use
JP4931312B2 (ja) * 1999-12-13 2012-05-16 ステリックス リミテッド ステロイドスルファターゼのインヒビターとしてのハロゲン化スルファメート−、ホスホネート−、チオホスホネート−、スルホネート−、およびスルホンアミド−化合物
US7335650B2 (en) 2000-01-14 2008-02-26 Sterix Limited Composition
JPWO2001081364A1 (ja) 2000-04-24 2004-01-08 協和醗酵工業株式会社 エストラ−１，３，５（１０）−トリエン誘導体
GB0025788D0 (en) * 2000-10-20 2000-12-06 Sterix Ltd Use
AU2004224053B2 (en) * 2003-03-24 2011-06-09 Sterix Limited Oestrogen derivatives as inhibitors of steroid sulphatase
GB0306718D0 (en) * 2003-03-24 2003-04-30 Sterix Ltd Compound
GB0306717D0 (en) * 2003-03-24 2003-04-30 Sterix Ltd Compound
GB0511190D0 (en) * 2005-06-01 2005-07-06 Sterix Ltd Use
GB0624105D0 (en) * 2006-12-01 2007-01-10 Sterix Ltd Use
EP2149371A1 (en) * 2008-07-28 2010-02-03 PregLem S.A. Use of steroid sulfatase inhibitors for the treatment of preterm labor

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1398026A (en) * 1972-11-10 1975-06-18 Jenapharm Veb Steroid esters
WO1993005064A1 (en) * 1991-08-29 1993-03-18 Imperial College Of Science, Technology And Medicine Steroid sulphatase inhibitors
WO1998024802A2 (en) * 1996-12-05 1998-06-11 Imperial College Of Science Technology And Medicine Compound

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3046719C2 (de) * 1980-12-11 1983-02-17 Klinge Pharma GmbH, 8000 München 1,1,2-Triphenyl-but-1-en-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel
US5273993A (en) * 1989-06-12 1993-12-28 A. H. Robins Company, Incorporated Compounds having one or more aminosulfonyloxy radicals useful as pharmaceuticals
US6083978A (en) * 1996-03-05 2000-07-04 Sterix Limited Compounds with a sulfamate group
US6011024A (en) * 1991-08-28 2000-01-04 Imperial College Of Science Technology & Medicine Steroid sulphatase inhibitors
GB9118465D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
US5556847A (en) * 1994-10-27 1996-09-17 Duquesne University Of The Holy Ghost Methods of effecting memory enhancement mediated by steroid sulfatase inhibitors
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
US5567831A (en) * 1995-08-16 1996-10-22 Duguesne University Of The Holy Ghost Non-steroidal sulfatase inhibitor compounds and their method of use
US5763492A (en) 1996-10-01 1998-06-09 Duguesne University Of The Holy Ghost Methods for effecting memory enhancement mediated by non-steroidal sulfatase inhibitors
GB2331987B (en) 1997-12-04 2002-11-27 Imperial College Polycyclic sulphamate inhibitors of oestrone sulphatase
US6248780B1 (en) 1998-10-01 2001-06-19 Duquesne University Of The Holy Ghost Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1398026A (en) * 1972-11-10 1975-06-18 Jenapharm Veb Steroid esters
WO1993005064A1 (en) * 1991-08-29 1993-03-18 Imperial College Of Science, Technology And Medicine Steroid sulphatase inhibitors
WO1998024802A2 (en) * 1996-12-05 1998-06-11 Imperial College Of Science Technology And Medicine Compound

Also Published As

Publication number Publication date
US20020198396A1 (en) 2002-12-26
ATE451107T1 (de) 2009-12-15
DE69841374D1 (de) 2010-01-21
ES2337427T3 (es) 2010-04-23
GB2331987A (en) 1999-06-09
GB2331987A9 (en) 1900-01-01
EP1051178B1 (en) 2009-12-09
US6670353B2 (en) 2003-12-30
AU1345899A (en) 1999-06-16
JP2001524525A (ja) 2001-12-04
EP1051178A1 (en) 2000-11-15
WO1999027936A1 (en) 1999-06-10
GB9725749D0 (en) 1998-02-04

Similar Documents

Publication Publication Date Title
IL125752A0 (en) Non-steroidal polycyclic ring sulphamate derivatives their preparation and their use as oestrone sulphatase inhibitors
GB2331987B (en) Polycyclic sulphamate inhibitors of oestrone sulphatase
GB2331988B (en) Polycyclic sulphamate inhibitors or oestrone sulphatase
ES2195970T3 (es) L-ribavirina y usos de la misma.
ES2114487B1 (es) Mezcla estabilizante sinergistica.
UA32582C2 (uk) Двигун внутрішнього згоряння та спосіб (варіанти) його експлуатації
ZA981936B (en) Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase.
NO307336B1 (no) 2-[(Dihydro)pyrazolyl-3'-oksylmetylen]anilider, anvendelse derav, samt middel inneholdende forbindelsen og mellomprodukter for fremstilling av forbindelsen
HU9403323D0 (en) 4-mercaptioacetylamino-[2] benzazepinone(3) derivatives, and use as enkephalinase inhibitors
BG104117A (en) Universally applicable blood plasma
NZ503308A (en) Alpha-ketoamide multicatalytic protease inhibitors
ES2138247T3 (es) Composicion y uso.
EP1310508A3 (en) Estrogen sulfamate sulphatase inhibitors
AU8974298A (en) 1,4,7,10-tetraazabicyclo{8.2.2}tetradecan-2-one, a process for the preparation thereof and the use thereof for the preparation of tetraazamacrocycles
PL309282A1 (en) Application of 2-amino-6-n-propyl-amino- 4,5,6,7-tetrahydrobenzothiasole (pramipexol) as an antidepressant
NO20002676L (no) Androgene steroidforbindelser og en fremgangsmÕte for fremstilling og anvendelse av samme
TR200001288T2 (tr) Östrojen yoksunluğu sendromunun tedavisinde faydalı 2-arilbenzo (b) tiyofenler.
BR9509741A (pt) Composto e uso de composto
BG103098A (en) Colour composition including an agent contaning pyrogalols, salt of iron (ii) and organic acid
GB2324091A (en) Metalloproteinase inhibitors
EP0433855A3 (en) N- and o-substituted aminophenol derivatives, intermediates for their preparation, their use as hydrolase substrates, a corresponding assay and diagnostic agents
TR199701298T1 (xx) Tetralinler.
NO985079L (no) Eksplosiv formulering
ZA988508B (en) Novel stereoselective processes for the preparation of gabapentin and anologues thereof
AR008474A1 (es) Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20141204